TAF1 Antikörper

Produktnummer ABIN6945114

Produktdetails anti-TAF1 Antikörper

Target: TAF1 (TAF1 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 250kDa (TAF1))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAF1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Affinity purification

Immunogen: Polyclonal antibody raised in rabbit against TAF1 using a KLH-conjugated synthetic peptide.

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IF()

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.15 g/L

Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 and 0.01 % sodium azide.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu TAF1

Target: TAF1 (TAF1 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 250kDa (TAF1))

Andere Bezeichnung: TAF1 (TAF1 Produkte)

Synonyme: BG:DS00004.13 antikoerper, CG17603 antikoerper, Dmel\\CG17603 antikoerper, EfW1 antikoerper, SR3-5 antikoerper, TAF antikoerper, TAF1 antikoerper, TAF200 antikoerper, TAF230 antikoerper, TAF250 antikoerper, TAF250/230 antikoerper, TAFII-250 antikoerper, TAFII250 antikoerper, TAF[II]250 antikoerper, TAF[[II]] antikoerper, TAF[[II]]230 antikoerper, TAF[[II]]250 antikoerper, TAF[[II]]250/230 antikoerper, TFIID antikoerper, TFIID TAF250 antikoerper, Taf1p antikoerper, Taf200 antikoerper, Taf230 antikoerper, Taf250 antikoerper, Taf[[II]]250 antikoerper, cel antikoerper, cell antikoerper, d230 antikoerper, dTAF230 antikoerper, dTAF250 antikoerper, dTAFII250 antikoerper, dTAF[[II]]230 antikoerper, dTAF[[II]]250 antikoerper, dmTAF1 antikoerper, dmTAF[[II]]230 antikoerper, l(3)84Ab antikoerper, p230 antikoerper, 250kDa antikoerper, AU015687 antikoerper, B430306D02Rik antikoerper, Ccg-1 antikoerper, Ccg1 antikoerper, KAT4 antikoerper, N-TAF1 antikoerper, Taf2a antikoerper, RGD1562050 antikoerper, BA2R antikoerper, CCG1 antikoerper, CCGS antikoerper, DYT3 antikoerper, DYT3/TAF1 antikoerper, NSCL2 antikoerper, OF antikoerper, P250 antikoerper, TAF2A antikoerper, XDP antikoerper, TAF(II)250 antikoerper, p250 antikoerper, TBP-associated factor 1 antikoerper, TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa antikoerper, transcription initiation factor TFIID subunit 1 antikoerper, transcription initiation factor TFIID, subunit TAF1 antikoerper, TATA-box binding protein associated factor 1 antikoerper, Taf1 antikoerper, TAF1 antikoerper, LOC5567420 antikoerper, CpipJ_CPIJ003658 antikoerper, TAF11.1 antikoerper, HAF1501 antikoerper, HAF1502 antikoerper, LOC100457071 antikoerper

Hintergrund:

Synonyms: TAFII250, p250, BA2R, CCG1, CCGS, TAF2A, KAT4, NSCL2, DYT3

Background: Largest component and core scaffold of the TFIID basal transcription factor complex (PubMed:25412659, PubMed:27007846). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity (PubMed:25412659). Essential for progression of the G1 phase of the cell cycle (PubMed:11278496, PubMed:15053879, PubMed:2038334, PubMed:8450888, PubMed:8625415, PubMed:9660973, PubMed:9858607). Exhibits histone acetyltransferase activity towards histones H3 and H4 (PubMed:15870300).

Gen-ID: 6872

UniProt: P21675